JFG
OLMA icon

Jefferies Financial Group’s Olema Pharmaceuticals OLMA Stock Holding History

Jefferies Financial Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$138K Buy
11,000
+4,000
+57% +$53.6K ﹤0.01% 1511
2026
Q1 		$104K Buy
7,000
+4,000
+133% +$89K ﹤0.01% 1595
2025
Q4 		$75K Buy
+3,000
New +$53.4K ﹤0.01% 1733

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Jefferies Financial Group's OLMA Position: Q2 2026 in Review

Jefferies Financial Group increased its Olema Pharmaceuticals (OLMA) stake by 57% in Q2 2026, buying an estimated $53.6K and bringing the position to 11,000 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #1511.

Jefferies Financial Group first reported a position in OLMA in Q4 2025 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Jefferies Financial Group held 11,000 shares of Olema Pharmaceuticals worth $138K as of Q2 2026.
  • Jefferies Financial Group bought 4,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $53.6K.
  • Olema Pharmaceuticals made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1511 holding.
  • Jefferies Financial Group first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.